Dongkook enters blood glucose monitoring market along with international company

Dongkook Pharmaceutical held a signing ceremony with an international diabetes management company, Ascensia Diabetes Care, at its head office on the 7^th, and signed a approval and sales agreement of the Self Monitoring of Blood Glucose(SMBG) business in Korea.

The agreement was concluded for Dongkook Pharmaceutical to sell the series of blood glucose self-monitoring devices, ‘Breeze2’ and ‘Con...